Release Date: 24/09/10 15:33 Summary: Change of Name of Responsible Entity Price Sensitive: No Download Document 46.32KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%